Pharmaceutical Care Management Association President and CEO JC Scott issued a letter to the Trump Administration’s COVID-19 Task Force outlining pharmacy benefit managers’ commitment to offering patients assistance with obtaining prescribed prescription drug regimens.
WASHINGTON, March 10, 2020 /PRNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued a letter to the Trump Administration’s COVID-19 Task Force outlining pharmacy benefit managers’ (PBMs) commitment to offering patients assistance with obtaining prescribed prescription drug regimens. PBMs also stand ready to support federal, state, and local public health agencies as they fight COVID-19.
Click here to read the letter.
“We recognize the essential role that prescription drugs play in helping hundreds of millions of Americans maintain good health,” said Scott. “While COVID-19 itself is a new public health challenge, our companies have substantial experience in helping to mitigate prescription drug access concerns. In the event a national emergency is declared, our companies are fully prepared to provide early access to prescription refills, access to therapeutic alternatives in the event of COVID-19 related shortages, and address pharmacy access barriers.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 270 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.
View original content to download multimedia:http://www.prnewswire.com/news-releases/pbms-affirm-readiness-to-assist-patients-with-covid-19-301020871.html
SOURCE Pharmaceutical Care Management Association
